News | Health & Safety
30 Mar 2017 19:37
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     30 Mar: Smoking among bipolar sufferers a concern
     29 Mar: Dunedin study shows lead exposure effects
     28 Mar: Kiwi to see more upside after Trump defeat
     28 Mar: Hayfever 'hiding' thunderstorm asthma risk
     27 Mar: NZ shares fall on Trump healthcare failure
     27 Mar: Hospital faulted for cancer patient's care
     24 Mar: Authorities warn of Auckland measles scare
     Top Stories

    RUGBY RUGBY
    Super Rugby round six preview panel More...


    BUSINESS BUSINESS
    Xero's 1m customer brings breakeven closer More...



     Today's News

    Entertainment:
    Pharrell Williams’ childhood is set to become the subject of a new musical 19:12

    Law and Order:
    Police seek info on man with dragon tattoo 18:57

    International:
    Acknowledge possible Afghan deaths: Mapp 18:47

    Entertainment:
    Elle King bought her LA home without seeing it in person 18:42

    Soccer:
    A-League round-25 preview panel 18:37

    Entertainment:
    Angelina Jolie wants to spend her 50s “travelling” to visit her children 18:12

    Rugby:
    Super Rugby round six preview panel 18:07

    Entertainment:
    Dannii Minogue is in a “very happy” place with her mysterious new man 17:42

    International:
    Samuel Thompson disappearance: Man charged with murder of missing Albion man 17:27

    Health & Safety:
    Smoking among bipolar sufferers a concern 17:27


     News Search






    Power Search


    © 2017 New Zealand City Ltd